Senior Lecturer in Viral Immunology, University of Birmingham
Dr Stamataki is interested in applying immunology and cell biology methodologies to understand liver diseases from viral, autoimmune or metabolic injury. Her background is in virus transmission, neutralising antibodies and immunotherapy for hepatitis viruses. Dr Stamataki's team are using authentic human liver tissues to develop new therapies that restore immune regulation in liver inflammation and cancer.
Aug 26, 2020 11:16 am UTC| Health
Scientists in Hong Kong have reported the first confirmed case of reinfection with the coronavirus that causes COVID-19, reportedly backed up by genetic sequences of the two episodes of the 33-year-old mans infections in...